Citation Impact
Citing Papers
Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes
2020 StandoutNobel
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
2019
Machine learning predicts new anti-CRISPR proteins
2020 StandoutNobel
Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage
2022 StandoutNobel
Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2
2019 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing
2018
Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States
2019
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Controlling and enhancing CRISPR systems
2020 StandoutNobel
Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins
2019
A Broad-Spectrum Inhibitor of CRISPR-Cas9
2017 StandoutNobel
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Bridge helix arginines play a critical role in Cas9 sensitivity to mismatches
2020 StandoutNobel
A thermostable Cas9 with increased lifetime in human plasma
2017 StandoutNobel
A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing
2018
Massively parallel kinetic profiling of natural and engineered CRISPR nucleases
2020 StandoutNobel
Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins
2018
Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine–Cysteine Bond Formation
2020 StandoutNobel
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes
2018 StandoutScienceNobel
Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance
2019
Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases
2019
Works of Peter Cameron being referenced
NmeCas9 is an intrinsically high-fidelity genome-editing platform
2018